Omeprazole, H2 blockers, and polyarthralgia: Case-control study

British Medical Journal

Volumn 315, Issue 7118, 1997, Pages 1283-

  Meier, Christoph R ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; RANITIDINE;

ARTHRALGIA; ARTICLE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; ADULT; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; RISK FACTOR;

ADULT; ANTI-ULCER AGENTS; ARTHRALGIA; CASE-CONTROL STUDIES; CIMETIDINE; COHORT STUDIES; HISTAMINE H2 ANTAGONISTS; HUMANS; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; RISK FACTORS;

EID: 0031573130     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7118.1283     Document Type: Article

References (5)

1. Beutler M, Hartmann K, Kuhn M, Garunann J. Arthralgia and omeprazole. BMJ 1994;309:1620.
2. Jick H,Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
3. Garda Rodríguez LA, Jick H. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 1994;308:503-6.
4. García Rodríguez LA, Mannino S, Wallander M-A. Ocular safety of antiulcer drugs. Lancet 1995;345:1059-60.
5. SAS Institute. SAS/STAT. Version 6.11. Cary, NC: SAS Institute, 1995.